clinical trial Archives
Trial combines novel therapies for head and neck cancer
Apr. 27, 2023—Vanderbilt is launching a clinical trial that pairs an experimental vaccine with an established immunotherapy for recurrent, human papilloma virus (HPV)-related oropharyngeal cancer of the head and neck.
Trial seeks to expand therapies for biliary cancers
Feb. 23, 2023—A Vanderbilt clinical trial seeks to optimize the effect of immunotherapies for patients with biliary tract cancers who have already progressed on first-line therapy.
Study of two sepsis interventions finds identical outcomes
Feb. 2, 2023—Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.
Study to explore COVID’s impact on essential workers
Jan. 26, 2023—Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.
Vanderbilt Kennedy Center seeks adults 18-30 to study effects of noise on brain activity
Jan. 17, 2023—The Vanderbilt Kennedy Center is seeking adult participants (ages 18 to 30) for a research study investigating the effects of different noise conditions on brain activity during the Attentional Network Task.
VUMC-led COVID-19 clinical trial platform goes international
Jan. 5, 2023—The ACTIV-4 Host Tissue clinical trial platform, which is designed to investigate therapies targeting the host tissue response to COVID-19 to mitigate lung injury, is now being expanded internationally.
Clinical trial at VUMC tests novel treatment for asthma
Nov. 10, 2022—VUMC has begun enrolling patients with asthma in a clinical trial of a novel treatment: a medication approved to treat diabetes and obesity.
Study finds that reducing intake of simple sugars improves GERD
Oct. 6, 2022—A Vanderbilt study found that reducing dietary carbohydrates improved both symptoms and objective measurements of gastroesophageal reflux disease (GERD) in a randomized controlled trial.
VUMC study will evaluate alternative strategies for administering monkeypox vaccine
Sep. 7, 2022—Vanderbilt is seeking about 30 healthy adults of diverse backgrounds to participate in a national clinical trial to evaluate alternative strategies for administering the monkeypox vaccine
Study shows life-saving benefit of baricitinib for ventilated COVID patients
Feb. 7, 2022—Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.
Volunteers needed for study of nuts, abdominal fat and metabolic risk
Jan. 3, 2022—Help researchers learn more about how consuming nuts affects body weight, waist circumference and abdominal fat. Researchers at Vanderbilt University Medical Center are looking for volunteers for a study that will compare a diet with mixed nuts as snacks to a diet with typical snacks to determine the effects on abdominal fat and risk for...
International study supports dupilumab for treatment of moderate-to-severe asthma in children
Dec. 8, 2021—In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11 with moderate-to-severe asthma, offering a new option to these patients.
